|
1
|
Davies L and Welch HG: Increasing
incidence of thyroid cancer in the United States, 1973–2002. JAMA.
295:2164–2167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guan HX, Shan ZY, Mi XY, Wang E and Teng
W: Incidence of thyroid carcinoma before and after universal salt
iodization: An 11-year retrospective analysis of pathological
reports. J Chin Med Univ. 35:284–285. 2006.
|
|
4
|
Liu YQ, Zhang SQ, Chen WQ, Chen LL, Zhang
SW, Zhang XD and Zheng RS: Trend of incidence and mortality on
thyroid cancer in China during 2003–2007. Zhonghua Liu Xing Bing
Xue Za Zh. 33:1044–1048. 2012.(In Chinese).
|
|
5
|
Wu ST, Sun GH, Hsu CY, Huang CS, Wu YH,
Wang HH and Sun KH: Tumor necrosis factor-α induces
epithelial-mesenchymal transition of renal cell carcinoma cells via
a nuclear factor kappa B-independent mechanism. Exp Biol Med
(Maywood). 236:1022–1029. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liotti F, Visciano C and Melillo RM:
Inflammation in thyroid oncogenesis. Am J Cancer Res. 2:286–297.
2012.PubMed/NCBI
|
|
7
|
Menicali E, Moretti S, Voce P, Romagnoli
S, Avenia N and Puxeddu E: Intracellular signal transduction and
modification of the tumor microenvironment induced by RET/PTCs in
papillary thyroid carcinoma. Front Endocrinol (Lausanne).
3:672012.PubMed/NCBI
|
|
8
|
Aust G, Heuer M, Laue S, Lehmann I,
Hofmann A, Heldin NE and Scherbaum WA: Expression of tumour
necrosis factor-alpha (TNF-α) mRNA and protein in pathological
thyroid tissue and carcinoma cell lines. Clin Exp Immunol.
105:148–154. 2006. View Article : Google Scholar
|
|
9
|
Bossowski A, Harasymczuk J, Moniuszko A,
Bossowska A, Hilczer M and Ratomski K: Cytometric evaluation of
intracellular IFN-γ and IL-4 levels in thyroid follicular cells
from patients with autoimmune thyroid diseases. Thyroid Res.
4:132011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jing Y, Han Z, Liu Y, Sun K, Zhang S,
Jiang G, Li R, Gao L, Zhao X, Wu D, et al: Mesenchymal stem cells
in inflammation microenvironment accelerates hepatocellular
carcinoma metastasis by inducing epithelial-mesenchymal transition.
PloS One. 7:e432722012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H, Wang HS, Zhou BH, Li CL, Zhang F,
Zhang G, Bu XZ, Cai SH and Du J: Epithelial-mesenchymal transition
(EMT) induced by TNF-a requires AKT/GSK-3b-mediated stabilization
of snail in colorectal cancer. PLoS One. 8:e566642013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Knauf JA, Sartor MA, Medvedovic M, et al:
Progression of BRAF-induced thyroid cancer is associated with
epithelial-mesenchymal transition requiring concomitant MAP kinase
and TGFβ signaling. Oncogene. 30:3153–3162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sancisi V, Gandolfi G, Ragazzi M, Nicoli
D, Tamagnini I, Piana S and Ciarrocchi A: Cadherin 6 is a new RUNX2
target in TGF-β signalling pathway. PloS One. 8:e754892013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Howard EW, Camm KD, Wong YC and Wang XH:
E-cadherin upregulation as a therapeutic goal in cancer treatment.
Mini Rev Med Chem. 8:496–518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bai Y, Kakudo K, Nakamura M, Ozaki T, Li
Y, Liu Z, Mori I, Miyauchi A and Zhou G: Loss of cellular
polarity/cohesiveness in the invasive front of papillary thyroid
carcinoma and periostin expression. Cancer Lett. 281:188–195. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vasko V, Espinosa AV, Scouten W, He H,
Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la
Chapelle A, et al: Gene expression and functional evidence of
epithelial-to-mesenchymal transition in papillary thyroid carcinoma
invasion. Proc Natl Acad Sci USA. 104:2803–2808. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T,
Miyauchi A, Taniguchi E and Mori I: Loss of cellular
polarity/cohesiveness in the invasive front of papillary thyroid
carcinoma, a novel predictor for lymph node metastasis; possible
morphological indicator of epithelial mesenchymal transition. J
Clin Pathol. 64:325–329. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Puppin C, Fabbro D, Dima M, Di Loreto C,
Puxeddu E, Filetti S, Russo D and Damante G: High periostin
expression correlates with aggressiveness in papillary thyroid
carcinomas. J Endocrinol. 197:401–408. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Braun J, Hoang V, Dralle H and Hüttelmaier
S: Downregulation of microRNAs directs the EMT and invasive
potential of anaplastic thyroid carcinomas. Oncogene. 29:4237–4244.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grände M, Franzen Å, Karlsson JO, Ericson
LE, Heldin NE and Nilsson M: Transforming growth factor-β and
epidermal growth factor synergistically stimulate epithelial to
mesenchymal transition (EMT) through a MEK-dependent mechanism in
primary cultured pig thyrocytes. J Cell Sci. 115:4227–4236. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ren J, Wang Y, Gao Y, Mehta SB and Lee CG:
FAT10 mediates the effect of TNF-α in inducing chromosomal
instability. J Cell Sci. 124:3665–3675. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shiozaki A, Bai X, Shen T, Moodley S,
Takeshita H, Fung SY, Wang Y, Keshavjee S and Liu M: Claudin 1
mediates TNFα-induced gene expression and cell migration in human
lung carcinoma cells. PLoS One. 7:e380492012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Borthwick LA, Gardner A, De Soyza A, Mann
DA and Fisher AJ: Transforming growth factor-β1 (TGF-β1) driven
epithelial to mesenchymal transition (EMT) is accentuated by tumour
necrosis factor α (TNFα) via crosstalk between the SMAD and NF-κB
pathways. Cancer Microenviron. 5:45–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
López-Novoa JM and Nieto MA: Inflammation
and EMT: An alliance towards organ fibrosis and cancer progression.
EMBO Mol Med. 1:303–314. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei
Y, Abbruzzese JL, Hortobagyi GN and Hung MC: Epidermal growth
factor receptor cooperates with signal transducer and activator of
transcription 3 to induce epithelial-mesenchymal transition in
cancer cells via up-regulation of TWIST gene expression. Cancer
Res. 67:9066–9076. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xue H, Wang W, Li Y, Shan Z, Li Y, Teng X,
Gao Y, Fan C and Teng W: Selenium upregulates
CD4+CD25+ regulatory T cells in
iodine-induced autoimmune thyroiditis model of NOD H-2h4
mice. Endocr J. 57:595–601. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY and Weinberg RA: The epithelial-mesenchymal transition
generates cells with properties of stem cells. Cell. 133:704–715.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu J and Brown R: Immunohistochemical
detection of epithelial mesenchymal transition associated with
stemness phenotype in anaplastic thyroid carcinoma. Int J Clin Exp
Pathol. 3:755–762. 2010.PubMed/NCBI
|
|
30
|
Fagman H, Grande M, Edsbagge J, Semb H and
Nilsson M: Expression of classical cadherins in thyroid
development: Maintena-nce of an epithelial phenotype throughout
organogenesis. Endocrinology. 144:3618–3624. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jensen K, Patel A, Hoperia V, Larin A,
Bauer A and Vasko V: Dynamic changes in E-cadherin gene promoter
methylation during metastatic progression in papillary thyroid
cancer. Exp Ther Med. 1:457–462. 2010.PubMed/NCBI
|
|
32
|
Rocha A, Soares P, Seruca R, Máximo V,
MatiasGuiu X, CameselleTeijeiro J and Sobrinho-Simões M:
Abnormalities of the E-adherin/catenin adhesion complex in
classical papillary thyroid carcinoma and in its diffuse sclerosing
variant. J Pathol. 194:358–366. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ulianich L, Garbi C, Treglia A, Punzi D,
Miele C, Raciti GA, Beguinot F, Consiglio E and Di Jeso B: ER
stress is associated with dedifferentiation and an
epithelial-to-mesenchymal transition-like phenotype in PC Cl3
thyroid cells. J Cell Sci. 121:477–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vuoriluoto K, Haugen H, Kiviluoto S,
Mpindi J, Nevo J, Gjerdrum C, Tiron C, Lorens JB and Ivaska J:
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and
migration by governing Axl expression in breast cancer. Oncogene.
30:1436–1448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mendez MG, Kojima S and Goldman RD:
Vimentin induces changes in cell shape, motility and adhesion
during the epithelial to mesenchymal transition. FASEB J.
24:1838–1851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kokkinos MI, Wafai R, Wong MK, Newgreen
DF, Thompson EW and Waltham M: Vimentin and epithelial-mesenchymal
transition in human breast cancer-observations in vitro and in
vivo. Cells Tissues Organs. 185:191–203. 2007. View Article : Google Scholar : PubMed/NCBI
|
